Scientific reports

International journal of cancer

Frontiers in immunology

biology direct

The Cochrane database of systematic reviews

Stem cell research

Frontiers in oncology

mutation research

journal of cellular physiology

pediatrics international : official journal of the japan pediatric society

cancer letters

pediatric hematology and oncology

neoplasia (new york, ny)

[1] Comet assay in neural cells as a tool to monitor DNA damage induced by chemical or physical factors relevant to environmental and occupational exposure.

[2] Blood product administration during high risk neuroblastoma therapy.

[3] Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.

[4] Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.

[5] Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture.

[6] Preclinical models for neuroblastoma: advances and challenges.

[7] Improvement of opsoclonus after congenital cataract surgery in an infant.

[8] Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4 CAR T Cell Efficacy.

[9] LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase.

[10] Karolinska Institutet Human Embryonic Stem Cell Bank.

[11] Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.

[12] downregulation and/or release of nkg2d ligands as immune evasion strategy of human neuroblastoma

[13] cell proliferation in neuroblastoma

[14] neuroblastoma in a 55-year-old patient: a case report

[15] A novel framework for horizontal and vertical data integration in cancer studies with application to survival time prediction models.

[16] cellular high-energy cavitation trauma - description of a novel in vitro trauma model in three different cell types.

[17] immunoexpression of cell cycle biomarkers in neuroblastoma samples and its correlation with prognostic factors imunoexpressão de biomarcadores do ciclo celular em amostras de neuroblastomas e sua relação com fatores prognósticos

[18] pediatric mandibular metastasis: a rare finding of neuroblastoma

[19] optimization of a neural stem-cell-mediated carboxylesterase/irinotecan gene therapy for metastatic neuroblastoma

[20] biotensegrity of the extracellular matrix: physiology, dynamic mechanical balance and implications in oncology and mechanotherapy.

[21] quantitative approach to assist neuroblastoma assessment by measuring i-123 mibg uptake in scintigraphic images

[22] corrigendum: glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies

[23] alk inhibitors, a pharmaceutical perspective

[24] morphometric evaluation of nb84, synaptophysin and agnor is useful for the histological diagnosis and prognosis in peripheral neuroblastic tumors (pnts) a avaliação morfométrica de nb84, sinaptofisina e agnor é útil para o dignóstico histológico e prognóstico dos tumores neuroblásticos periféricos (pnts)

[25] MYELOFIBROSIS IN CHILDREN: Experience at a Single Tertiary Care Center in India

[26] [Cu(TPMA)(Phen)](ClO): Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity.

[27] Cytotoxic phenanthroline derivatives alter metallostasis and redox homeostasis in neuroblastoma cells.

[28] Predicting clinical outcomes in neuroblastoma with genomic data integration.

[29] Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against HO- and Aβ-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells.

[30] Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against HO- and Aβ-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells.

[31] Antiproliferative, genotoxic and oxidant activities of cyclosativene in rat neuron and neuroblastoma cell lines

[32] Oxidative stress and related gene expression effects of cyfluthrin in human neuroblastoma SH-SY5Y cells: Protective effect of melatonin.

[33] Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.

[34] Design and Synthesis of CNb-targeted Flavones and Analogues with Neuroprotective Potential Against H<inf>2</inf>O<inf>2</inf>- and Aβ<inf>1-42</inf>-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells

[35] PIWI-interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells.

[36] Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.

[37] Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells

[38] Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma.

[39] Blood product administration during high risk neuroblastoma therapy.

[40] Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.

[41] Redox-proteomes of human NOS1-transduced versus MOCK SH-SY5Y neuroblastoma cells under full nutrition, serum-free starvation, and rapamycin treatment

[42] Deep proteome of human nNOS/NOS1-positive versus MOCK SH-SY5Y neuroblastoma cells under full nutrition, serum free starvation and rapamycin treatment

[43] Effects of chronic intermittent ethanol exposure and withdrawal on neuroblastoma cell transcriptome.

[44] Preclinical models for neuroblastoma: advances and challenges.

[45] Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cells

[46] High-dose I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan.

[47] APEX1 Polymorphisms and Neuroblastoma Risk in Chinese Children: A Three-Center Case-Control Study

[48] LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase.

[49] Design, synthesis and characterization of biogenic chloroquine silver nanoparticles as potential anticancer agent against neuroblastoma cells

[50] Biological Activities of Cyclic and Acyclic B-Type Laxaphycins in SH-SY5Y Human Neuroblastoma Cells

[51] Biological Activities of Cyclic and Acyclic B-Type Laxaphycins in SH-SY5Y Human Neuroblastoma Cells

[52] downregulation and/or release of nkg2d ligands as immune evasion strategy of human neuroblastoma

[53] cellular uptake of quercetin and luteolin and their effects on monoamine oxidase-a in human neuroblastoma sh-sy5y cells

[54] n-myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells

[55] cell proliferation in neuroblastoma

[56] mdm2 deficiency suppresses mycn-driven neuroblastoma tumorigenesis in vivo

[57] neuroblastoma in a 55-year-old patient: a case report

[58] low-grade esthesioneuroblastoma presenting as siadh: a review of atypical manifestations

[59] adult versus pediatric neuroblastoma: the m.d. anderson cancer center experience

[60] immunoexpression of cell cycle biomarkers in neuroblastoma samples and its correlation with prognostic factors imunoexpressão de biomarcadores do ciclo celular em amostras de neuroblastomas e sua relação com fatores prognósticos

[61] a rare tumor in the cervical sympathetic trunk: ganglioneuroblastoma

[62] cell line-dependent variability of coordinate expression of p75ntr and crabp1 and modulation of effects of fenretinide on neuroblastoma cells

[63] pediatric mandibular metastasis: a rare finding of neuroblastoma

[64] primary intraspinal ganglioneuroblastoma of the thoracic spine: a rare case report

[65] ferulic acid regulates the nrf2/heme oxygenase-1 system and counteracts trimethyltin-induced neuronal damage in the human neuroblastoma cell line sh-sy5y.

[66] optimization of a neural stem-cell-mediated carboxylesterase/irinotecan gene therapy for metastatic neuroblastoma

[67] olfactory neuroblastoma treated by endoscopic surgery followed by combined external beam radiation and gamma knife for optic nerve and chiasm sparing: a case report

[68] quantitative approach to assist neuroblastoma assessment by measuring i-123 mibg uptake in scintigraphic images

[69] corrigendum: glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies

[70] neoadjuvant chemotherapy in locally advanced and borderline resectable nonsquamous sinonasal tumors (esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation)

[71] the large conductance ca2+ -activated k+ (bkca) channel regulates cell proliferation in sh-sy5y neuroblastoma cells by activating the staurosporine-sensitive protein kinases

[72] a potent (r)-alpha-bis-lipoyl derivative containing 8-hydroxyquinoline scaffold: synthesis and biological evaluation of its neuroprotective capabilities in sh-sy5y human neuroblastoma cells

[73] effect of hsv-il12 loaded tumor cell-based vaccination in a mouse model of high-grade neuroblastoma

[74] neuroblastoma in the elderly and siadh: case report and review of the literature

[75] a model for spheroid versus monolayer response of sk-n-sh neuroblastoma cells to treatment with 15-deoxy-pgj2

[76] Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation

[77] Histone Methyltransferases G9a/<i>Ehmt2</i> and GLP/<i>Ehmt1</i> Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma

[78] Neuroblastoma in a 3-year-old boy presenting with pain in the bilateral hip and abdomen

[79] Correction to: Downregulation of fibronectin 1 attenuates ATRA‑induced inhibition of cell migration and invasion in neuroblastoma cells (Molecular and Cellular Biochemistry, (2021), 476, 10, (3601-3612), 10.1007/s11010-021-04113-5)